Journal ArticleAm Heart J · October 2025
BACKGROUND: Sub-analyses of key trials suggest a preferential benefit for specific heart failure with preserved ejection fraction (HFpEF) therapies in women. This work investigated treatment effects between women and men in the PARAGLIDE-HF (Prospective co ...
Full textLink to itemCite
